Skip to main content
. 2021 Mar 26;10(2):124–133. doi: 10.4103/EUS-D-20-00159

Table 2.

Comparison of the modalities of treatment between the SAME TIME and TWO TIMES groups

Characteristics All patients (n=31), n (%) SAME TIME (n=15), n (%) TWO TIMES (n=16), n (%) P*
Postdrainage chemotherapy
 No 16 (51.6) 9 (60) 7 (43.75) 0.37
 Yes 15 (48.4) 6 (40) 9 (56.25)
Hospital stay (days)
 Median (minimum-maximum) 8 (1-26) 6 (1-22) 9.5 (3-26) 0.04
 Mean (SD) 10.1 (7.4) 7.5 (6.8) 12.6 (7.3)
Drainage
 EUS-HG 11 (35.5) 7 (46.7) 4 (25) 0.21
 Other 20 (64.5) 8 (53.3) 12 (75)
Biliary drainage modality
 ERCP 8 (25.8) 4 (26.6) 4 (25) 0.45
 EUS-CD 1 (3.2) 1 (6.25)
 EUS-HG 11 (35.5) 7 (46.7) 4 (25)
 PCTBD 11 (35.5) 4 (26.7) 7 (43.75)

PCTBD: Percutaneous transhepatic biliary drainage; SD: Standard deviation; CD: Choledocoduodenostomy; ERCP: Endoscopic retrograde cholangio-pancreatography; HG: Hepaticogastrostomy